4.7 Review

Surgery for acromegaly: Indications and goals

期刊

FRONTIERS IN ENDOCRINOLOGY
卷 13, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fendo.2022.924589

关键词

acromegaly; adenoma; pituitary; endonasal; endoscopic; skull-base; transnasal

资金

  1. Nell W. and William S. Elkin Research Fellowship in Oncology, Winship Cancer Institute, Emory University Hospital, Atlanta, GA
  2. National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR002378, TL1TR002382]

向作者/读者索取更多资源

Acromegaly is a disease caused by excessive levels of growth hormone, usually due to hormone-secreting pituitary adenomas, leading to adverse effects in multiple systems. Diagnosis involves measuring serum growth hormone and IGF-1 levels and obtaining an MRI to evaluate pituitary adenoma function. Complete surgical resection of the growth hormone-secreting adenoma is the preferred treatment for acromegaly, aiming for biochemical remission. Medical and radiation therapies are available if biochemical cure is not achieved after surgery.
Acromegaly is a disease that occurs secondary to high levels of GH, most often from a hormone-secreting pituitary adenoma, with multisystem adverse effects. Diagnosis includes serum GH and IGF-1 levels, and obtaining an MRI pituitary protocol to assess for a functional pituitary adenoma. Attempted gross total resection of the GH-secreting adenoma is the gold standard in treatment for patients with acromegaly for a goal of biochemical remission. Medical and radiation therapies are available when patients do not achieve biochemical cure after surgical therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据